PSNC Briefing 050/18: Flu Vaccination Service 2018/19: Adjuvanted trivalent inactivated influenza vaccine (aTIV)

PSNC Briefing 050/18: Flu Vaccination Service 2018/19: Adjuvanted trivalent inactivated influenza vaccine (aTIV)

This is the first year of the pharmacy Flu Vaccination Service, that different vaccines have been recommended for different eligible groups. There is also an added complexity this year, due to the fact that contractors will receive a phased delivery of Fluad® and that there is a recommended priority order for patients in the 65 years and above eligible group.

There have been several documents and news stories published containing information about aTIV and the recommendations for using it; a publication timeline is set out in Annex A as background information. This PSNC Briefing provides a summary of relevant information for contractors.

PSNC Briefing 050/18: Flu Vaccination Service 2018/19: Adjuvanted trivalent inactivated influenza vaccine (aTIV)

If you have any queries on this PSNC Briefing or you require more information, please contact Zainab Al-Kharsan, Service Development Pharmacist.

To browse other PSNC briefings on services and commissioning click here.



Latest Services and Commissioning news

View more Services and Commissioning news >